Información del artículo
Abstract
Objective
To review the scientific literature concerning the classification of fibromyalgia (FM), including previous studies focusing on the gnosologic evaluation of FM, with the aim of proposing a classificatory hypothesis based on the current scientific evidence.
MethodsSystematic review using a baseline MEDLINE search. Search terms included “fibromyalgia” and “classification.” Additional articles were identified through a comprehensive manual search of the references of retrieved articles.
ResultsThis systematic review has identified, on the one hand, several classificatory proposals based on psychopathological aspects, and, on the other hand, the key role of associated diseases. Based on the scientific evidence currently available, the following FM subsets were defined: patients with no associated processes (type I FM), patients with associated rheumatic/autoimmune chronic diseases (type II FM), patients with severe psychiatric disorders (type III FM) and patients with simulated FM (type IV FM).
ConclusionsFew studies have specifically analyzed the classification of FM into subgroups with a more homogeneous clinical expression. Correct classification of patients with FM requires the integration of two key concepts (psychopathological evaluation and coexistence of comorbid processes), with an individual diagnostic evaluation by a multidisciplinary team.
Keywords:
Fibromyalgia
Classification
Chronic pain
Resumen
Objetivo
Recopilar la información existente sobre la clasificación de la fibromialgia (FM), analizar los antecedentes relevantes en relación con una subdivisión nosológica y proponer una hipótesis clasificatoria fundamentada en la evidencia científica existente en la actualidad.
MetodologíaRevisión sistemática de la literatura mediante búsqueda en la página web PubMed. Los términos de búsqueda en MEDLINE fueron «fibromyalgia» y «classification». Se realizó una búsqueda manual adicional entre las referencias de los artículos seleccionados.
ResultadosLa revisión sistemática de la literatura ha permitido identificar, por una parte, la existencia de varias propuestas clasificatorias esencialmente basadas en criterios psicopatológicos y, por otra parte, la importancia de evaluar las enfermedades relacionadas con la FM. Según la evidencia analizada, se han identificado los siguientes subgrupos clasificatorios en el paciente que cumple los criterios vigentes de 1990: pacientes sin ninguna enfermedad concomitante (FM tipo I), pacientes con enfermedades crónicas reumáticas y autoinmunitarias (FM tipo II), pacientes con grave alteración en la esfera psicopatológica (FM tipo III) y pacientes simuladores (FM tipo IV).
ConclusionesSon pocos los estudios que analizan de forma específica cómo identificar subgrupos de pacientes con FM con una expresión clínica más homogénea. El análisis ha permitido identificar que los principales aspectos a evaluar en la clasificación del paciente con FM son el perfil psicopatológico y la coexistencia de otros procesos. Una adecuada clasificación del paciente con FM sólo puede realizarse mediante una evaluación diagnóstica individualizada por parte de un equipo mutidisciplinario.
Palabras clave:
Fibromialgia
Clasificación
Dolor crónico
El Texto completo está disponible en PDF
References
[1.]
Consensus Document on Fibromyalgia.
The Copenhagen Declaration. Journal Musculoskeletal Pain.
The Haworth Press, (1993),
[2.]
WHO.
International Statistical Classification of Diseases and Related Problems. ICD-10.
WHO, (1992),
[3.]
J. Rivera Redondo.
Controversias en el diagno¿ stico de fibromialgia.
Rev Esp Reumatol, 31 (2004), pp. 501-506
[4.]
M. Ramos-Casals, P. Brito-Zerón, J. Font.
The overlap of Sjögren's syndrome with other systemic autoimmune diseases.
Semin Arthritis Rheum, 36 (2007), pp. 246-255
[5.]
C. Salliot, L. Mouthon, M. Ardizzone, J. Sibilia, L. Guillevin, J.E. Gottenberg, et al.
Sjogren's syndrome is associated with and not secondary to systemic sclerosis.
Rheumatology (Oxford), 46 (2007), pp. 321-326
[6.]
M.G. Tektonidou, M. Anapliotou, P. Vlachoyiannopoulos, H.M. Moutsopoulos.
Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
Ann Rheum Dis, 63 (2004), pp. 1159-1161
[7.]
F. Wolfe, H.A. Smythe, M.B. Yunus, R.M. Bennett, C. Bombardier, D.L. Goldenberg, et al.
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.
Artritis Rheum, 33 (1990), pp. 160-172
[8.]
D.A. Provenzano, G.J. Fanciullo, R.N. Jamison, G.J. McHugo, J.C. Baird.
Computer assessment and diagnostic classification of chronic pain patients.
Pain Med, 8 (2007), pp. S167-S175
[9.]
Cöster L, Kendall S, Gerdle B, Henriksson C, Henriksson KG, Bengtsson A. Chronic widespread musculoskeletal pain – A comparison of those who meet criteria for fibromyalgia and those who do not. Eur J Pain. Nov 14, 2007[Epub ahead of print].
[10.]
G.K. Endresen.
Fibromyalgia: a rheumatologic diagnosis?.
Rheumatol Int, 27 (2007), pp. 999-1004
[11.]
J.G. McVeigh, M.B. Finch, D.A. Hurley, J.R. Basford, J. Sim, G.D. Baxter.
Tender point count and total myalgic score in fibromyalgia: changes over a 28-day period.
Rheumatol Int, 27 (2007), pp. 1011-1018
[12.]
R.N. Harden, G. Revivo, S. Song, D. Nampiaparampil, G. Golden, M. Kirincic, et al.
A critical analysis of the tender points in fibromyalgia.
Pain Med, 8 (2007), pp. 147-156
[13.]
N. Tastekin, M. Birtane, K. Uzunca.
Which of the three different tender points assessment methods is more useful for predicting the severity of fibromyalgia syndrome?.
Rheumatol Int, 27 (2007), pp. 447-451
[14.]
A. Cott, W. Parkinson, M.J. Bell, J. Adachi, M. Bédard, A. Cividino, et al.
Interrater reliability of the tender point criterion for fibromyalgia.
J Rheumatol, 19 (1992), pp. 1955-1959
[15.]
P. Croft, J. Burt, J. Schollum, E. Thomas, G. Macfarlane, A. Silman.
More pain, more tender points: is fibromyalgia just one end of a continuous spectrum?.
Ann Rheum Dis, 55 (1996), pp. 482-485
[16.]
I. Khostanteen, E.R. Tunks, C.H. Goldsmith, J. Ennis.
Fibromyalgia: can one distinguish it from simulation? An observer-blind controlled study.
J Rheumatol, 27 (2000), pp. 2671-2676
[17.]
S.M. Campbell, S. Clark, E.A. Tindall, M.E. Forehand, R.M. Bennett.
Clinical characteristics of fibrositis. I. A blinded controlled study of symptoms and tender points.
Arthritis Rheum, 26 (1983), pp. 817-824
[18.]
P. Croft, J. Schollum, A.J. Silman.
Population study of tender point counts and pain as evidence of fibromialgia.
BMJ, 310 (1994), pp. 696-699
[19.]
T. Schochat, H. Raspe.
Elements of fibromialgia in an open population.
Rheumatology, 42 (2002), pp. 829-835
[20.]
D.C. Turk.
The potential of treatment matching for subgroups of patients with chronic pain: lumping versus splitting.
Clin J Pain, 21 (2005), pp. 44-55
[21.]
A.T. Masi, K.P. White, J.J. Pilcher.
Person-centered approach to care, teaching, and research in fibromyalgia syndrome: justification from biopsychosocial perspectives in populations.
Semin Arthritis Rheum, 32 (2002), pp. 71-93
[22.]
E.F. Rosenberg.
Classification and management of fibrositis.
Med Clin North Am, 42 (1958), pp. 1613-1627
[23.]
C. Vitali, A. Taroni.
Criteria for the classification of primary fibromyalgia syndrome (fibrositis): an unsolved problem.
Clin Exp Rheumatol, 7 (1989), pp. 1-3
[24.]
D.C. Turk, A. Okifuji, J.D. Sinclair, T.W. Starz.
Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment.
Arthritis Care Res, 11 (1998), pp. 397-404
[25.]
D.C. Turk, A. Okifuji, J.D. Sinclair, T.W. Starz.
Pain, disability, and physical functioning in subgroups of patients with fibromyalgia.
J Rheumatol, 23 (1996), pp. 1255-1262
[26.]
D.C. Turk, H. Flor.
Primary fibromyalgia is greater than tender points: toward a multiaxial taxonomy.
J Rheumatol Suppl, 19 (1989), pp. 80-86
[27.]
I.M. Hurtig, R.I. Raak, S.A. Kendall, B. Gerdle, L.K. Wahren.
Quantitative sensory testing in fibromyalgia patients and in healthy subjects: identification of subgroups.
Clin J Pain, 17 (2001), pp. 316-322
[28.]
R. Raak, I. Hurtig, L.K. Wahren.
Coping strategies and life satisfaction in subgrouped fibromyalgia patients.
Biol Res Nurs, 4 (2003), pp. 193-202
[29.]
T. Giesecke, D.A. Williams, R.E. Harris, T.R. Cupps, X. Tian, T.X. Tian, et al.
Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors.
Arthritis Rheum, 48 (2003), pp. 2916-2922
[30.]
L. Blasco Claros, M. Mallo Caño, A. Mencía Presa, J. Franch Barceló, P. Casaus Satamán, J. Peña Roca, et al.
Clinical profiles in fibromyalgia patients of the community mental health center: a predictive index of psychopathological severity.
Actas Esp Psiquiatr, 34 (2006), pp. 112-122
[31.]
W. Müller, E.M. Schneider, T. Stratz.
The classification of fibromyalgia syndrome.
Rheumatol Int, 27 (2007), pp. 1005-1010
[32.]
H. Bliddal, B. Danneskiold-Samsøe.
Chronic widespread pain in the spectrum of rheumatological diseases.
Best Pract Res Clin Rheumatol, 21 (2007), pp. 391-402
[33.]
P.T. Weir, G.A. Harlan, F.L. Nkoy, S.S. Jones, K.T. Hegmann, L.H. Gren, et al.
The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes.
J Clin Rheumatol, 12 (2006), pp. 124-128
[34.]
L.A. Aaron, M.M. Burke, D. Buchwald.
Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder.
Arch Intern Med, 160 (2000), pp. 221-227
[35.]
I. Giles, D. Isenberg.
Fatigue in primary Sjögren's syndrome: Is there a link with the fibromialgia syndrome?.
Ann Rheum Dis, 59 (2000), pp. 875-878
[36.]
P. Ostuni, C. Botsios, P. Sfriso, L. Punzi, F. Chieco-Bianchi, L. Semerano, et al.
Fibromyalgia in Italian patients with primary Sjogren's syndrome.
Joint Bone Spine, 69 (2002), pp. 51-57
[37.]
R. Dohrenbusch, M. Gruterich, E. Genth.
Fibromyalgia and Sjogren syndrome–clinical and methodological aspects.
Z Rheumatol, 55 (1996), pp. 19-27
[38.]
M. Tishler, Y. Barak, D. Paran, M. Yaron.
Sleep disturbances, fibromyalgia and primary Sjogren's syndrome.
Clin Exp Rheumatol, 15 (1997), pp. 71-74
[39.]
R. Belenguer, M. Ramos-Casals, P. Brito-Zerón, J. del Pino, J. Sentís, S. Aguiló, et al.
Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren's syndrome.
Clin Exp Rheumatol, 23 (2005), pp. 351-356
[40.]
F. Wolfe, M.A. Cathey.
Prevalence of primary and secondary fibrositis.
J Rheumatol, 10 (1983), pp. 965-968
[41.]
D. Buskila, D.D. Gladman, P. Langevitz, S. Urowitz, H.A. Smythe.
Fibromyalgia in human immunodeficiency virus infection.
J Rheumatol, 17 (1990), pp. 1202-1206
[42.]
V. Aloush, J.N. Ablin, T. Reitblat, D. Caspi, O. Elkayam.
Fibromyalgia in women with ankylosing spondylitis.
Rheumatol Int, 27 (2007), pp. 865-868
[43.]
C. Vitali, A. Tavoni, R. Neri, P. Castrogiovanni, G. Pasero, S. Bombardieri.
Fibromyalgia features in patients with primary Sjögren's syndrome. Evidence of a relationship with psychological depression.
Scand J Rheumatol, 18 (1989), pp. 21-27
[44.]
R.W. Simms, C.A. Zerbini, N. Ferrante, J. Anthony, D.T. Felson, D.E. Craven.
Fibromyalgia syndrome in patients infected with human immunodeficiency virus. The Boston City Hospital Clinical AIDS Team.
Am J Med, 92 (1992), pp. 368-374
[45.]
S.S. Lee, H.J. Yoon, H.K. Chang, K.S. Park.
Fibromyalgia in Behçet's disease is associated with anxiety and depression, and not with disease activity.
Clin Exp Rheumatol, 23 (2005), pp. S15-S19
[46.]
M.K. Al-Izzi, A.S. Jabber.
Fibromyalgia in Iraqi patients with Behcet's disease.
J Med Liban, 52 (2004), pp. 86-90
[47.]
S. Yavuz, I. Fresko, V. Hamuryudan, S. Yurdakul, H. Yazici.
Fibromyalgia in Behçet's syndrome.
J Rheumatol, 25 (1998), pp. 2219-2220
[48.]
V. Chandran, S. Bhella, C. Schentag, D.D. Gladman.
Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis.
Ann Rheum Dis, 66 (2007), pp. 936-939
[49.]
E. Kozanoglu, A. Canataroglu, B. Abayli, S. Colakoglu, K. Goncu.
Fibromyalgia syndrome in patients with hepatitis C infection.
Rheumatol Int, 23 (2003), pp. 248-251
[50.]
C. Goulding, P. O’Connell, F.E. Murray.
Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition.
Eur J Gastroenterol Hepatol, 13 (2001), pp. 507-511
[51.]
J. Rivera, A. de Diego, M. Trinchet, A. García Monforte.
Fibromyalgia-associated hepatitis C virus infection.
Br J Rheumatol, 36 (1997), pp. 981-985
[52.]
D. Buskila, A. Shnaider, L. Neumann, D. Zilberman, N. Hilzenrat, E. Sikuler.
Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship.
Arch Intern Med, 157 (1997), pp. 2497-2500
[53.]
B. Kuriya, D.D. Gladman, D. Ibañez, M.B. Urowitz.
Quality of life over time in patients with systemic lupus erythematosus.
Arthritis Rheum, 59 (2008), pp. 181-185
[54.]
D. da Costa, M. Dritsa, S. Bernatsky, C. Pineau, H.A. Ménard, K. Dasgupta, et al.
Dimensions of fatigue in systemic lupus erythematosus: relationship to disease status and behavioral and psychosocial factors.
J Rheumatol, 33 (2006), pp. 1282-1288
[55.]
S. Akkasilpa, D. Goldman, L.S. Magder, M. Petri.
Number of fibromyalgia tender points is associated with health status in patients with systemic lupus erythematosus.
J Rheumatol, 32 (2005), pp. 48-50
[56.]
M. Valencia-Flores, M.H. Cardiel, V. Santiago, M. Resendiz, V.A. Castaño, O. Negrete, et al.
Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus.
Lupus, 13 (2004), pp. 4-10
[57.]
A.W. Friedman, M.B. Tewi, C. Ahn, G. McGwin Jr., B.J. Fessler, H.M. Bastian, LUMINA Study Group, et al.
Systemic lupus erythematosus in three ethnic groups: XV. Prevalence and correlates of fibromyalgia.
Lupus, 12 (2003), pp. 274-279
[58.]
P. Ostuni, C. Botsios, P. Sfriso, A. Bertagnin, F. Cozzi, A. Doria, et al.
Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome.
Minerva Med, 93 (2002), pp. 203-209
[59.]
J. Taylor, J. Skan, N. Erb, D. Carruthers, S. Bowman, C. Gordon, et al.
Lupus patients with fatigue is there a link with fibromyalgia syndrome?.
Rheumatology (Oxford), 39 (2000), pp. 620-623
[60.]
G. Littlejohn.
Regional pain syndrome: clinical characteristics, mechanisms and management.
Nat Clin Pract Rheumatol, 3 (2007), pp. 504-511
[61.]
H. Merskey.
Physical and psychological considerations in the classification of fibromyalgia.
J Rheumatol Suppl, 19 (1989), pp. 72-79
[62.]
J.T. Hudson, M.S. Hudson, L.F. Pliner, D.L. Goldenberg, H.G. Pope Jr..
Fibromyalgia and major affective disorders: a controlled phenomenology and family history study.
Am J Psychiatry, 142 (1985), pp. 441-446
[63.]
P. Fink.
Physical complaints and symptoms of somatizing patients.
J Pshychosom Res, 36 (1992), pp. 125-136
[64.]
R. Celiker, P. Borman, F. Ökaten, Y. Gökçe-Kutsal, O. Basgöze.
Psychological disturbance in fibromyalgia: relation to pain severity.
Clin Rheumatol, 16 (1997), pp. 179-184
[65.]
J.I. Hudson, B. Mangweth, H.G. Pope, C. de Col, A. Hausmann, S. Gutweniger, et al.
Family study of affective spectrum disorder.
Arch Gen Psychiatry, 60 (2003), pp. 170-177
[66.]
I. Hazemeijer, J.J. Rasker.
Fibromyalgia and the therapeutic domain. A philosophical study on the origins of fibromyalgia in a specific social setting.
Rheumatology (Oxford), 42 (2003), pp. 507-515
[67.]
W. Häuser.
Self-assessed pain intensity and disability in subjects diagnosed with fibromyalgia claiming retirement pension.
Schmerz, 21 (2007), pp. 539-544
[68.]
A. Vargas, A. Vargas, R. Hernández-Paz, J.M. Sánchez-Huerta, R. Romero-Ramírez, L. Amezcua-Guerra, et al.
Sphygmomanometry-evoked allodynia – a simple bedside test indicative of fibromyalgia: a multicenter developmental study.
J Clin Rheumatol, 12 (2006), pp. 272-274
[69.]
B.A. Pankoff, T.J. Overend, S.D. Lucy, K.P. White.
Reliability of the six-minute walk test in people with fibromyalgia.
Arthritis Care Res, 13 (2000), pp. 291-295
[70.]
J.M. Pearce.
Myofascial pain, fibromyalgia or fibrositis?.
Eur Neurol, 52 (2004), pp. 67-72
[71.]
P. Henningsen, S. Zipfel, W. Herzog.
Management of functional somatic syndromes.
Lancet, 369 (2007), pp. 946-955
[72.]
P. Henningsen, T. Zimmermann, H. Sattel.
Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review.
Psychosom Med, 65 (2003), pp. 528-533
[73.]
T. Schochat, H. Raspe.
Elements of fibromyalgia in an open population.
Rheumatology (Oxford), 42 (2003), pp. 829-835
[74.]
G.E. Ehrlich.
Fibromyalgia is not a diagnosis: comment on the editorial by Crofford and Clauw.
Arthritis Rheum, 48 (2003), pp. 276
[75.]
J.L. Quintner, M.L. Cohen.
Fibromyalgia falls foul of a fallacy.
Lancet, 353 (1999), pp. 1092-1094
[76.]
A. Bjørndal.
There are no diseases, there are only ill persons – about our use of the fibromyalgia concept.
Tidsskr Nor Laegeforen, 113 (1993), pp. 2793-2794
[78.]
E.W. McCleskey.
Neurobiology: new player in pain.
Nature, 424 (2003), pp. 729-730
[79.]
J.J. Rubin.
Psychosomatic pain: new insights and management strategies.
South Med J, 98 (2005), pp. 1099-1110
Copyright © 2009. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
